These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 32505732)
1. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer. Zhao E; Zhou C; Chen S Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732 [TBL] [Abstract][Full Text] [Related]
2. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer. Zhu C; Xiao D Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma. Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086 [TBL] [Abstract][Full Text] [Related]
4. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630 [TBL] [Abstract][Full Text] [Related]
5. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer. Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y PeerJ; 2024; 12():e17130. PubMed ID: 38515458 [TBL] [Abstract][Full Text] [Related]
6. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis. Wang K; Xie C; Chen D Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400 [TBL] [Abstract][Full Text] [Related]
7. Analysis and application of RNA binding protein gene pairs to predict the prognosis of gastric cancer. Ning ZK; Tian HK; Liu J; Hu CG; Liu ZT; Li H; Zong Z Heliyon; 2023 Jul; 9(7):e18242. PubMed ID: 37539127 [TBL] [Abstract][Full Text] [Related]
8. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer. Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study. Rao C; Tong J; Yang Y Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056 [TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes. Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791 [No Abstract] [Full Text] [Related]
11. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer. Zhao Z; Li S; Li S; Wang J; Lin H; Fu W Cancer Cell Int; 2021 Sep; 21(1):493. PubMed ID: 34530820 [TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis. Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568 [TBL] [Abstract][Full Text] [Related]
13. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis. Zhao Y; Hu S; Zhang J; Cai Z; Wang S; Liu M; Dai J; Gao Y Bioengineered; 2021 Dec; 12(1):5641-5654. PubMed ID: 34506251 [TBL] [Abstract][Full Text] [Related]
14. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
15. Clinical correlations and prognostic value of Nudix hydroxylase 10 in patients with gastric cancer. Chen D; Zhang R; Xie A; Yuan J; Zhang J; Huang Y; Zhang H; Zhang F Bioengineered; 2021 Dec; 12(2):9779-9789. PubMed ID: 34696672 [TBL] [Abstract][Full Text] [Related]
16. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Ma B; Li Y; Ren Y Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579 [TBL] [Abstract][Full Text] [Related]
17. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer. Zhao E; Zhou C; Chen S Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Yang KS; Xu CQ; Lv J Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442 [TBL] [Abstract][Full Text] [Related]
19. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer. Deng H; Li T; Wei F; Han W; Xu X; Zhang Y Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965 [No Abstract] [Full Text] [Related]
20. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value. He XY; Zhao J; Chen ZQ; Jin R; Liu CY Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]